1Mendelsohn J.The epidermal growth factor receptor as a target for cancer therapy [J]. Endocr Relat Cancer, 2001,8(1):3-9.
2Herbst R S.Review of epidermal growth factor receptor biology[J].Int J Radiat Oncol Biol Phys,2004,59(1):21-26.
3Raben D,Bianco C, Milas L,et al.Targetea merapies and radiation for the treatment of head and neck cancer:are we making progress?[J].Semin in Radiat Oncol,2004,14 (2):139-152.
7Parkin D M, Bray F, Ferlay J, et al. Estimating the world cancer burden:Globocan 2000[J].Int J Cancer, 2001,94(2): 153-156.
8Rosell R, Monzo M, O, Brate A, et al.Translational oncogenomics:toward rational therapeutic decision-making [J].Curr Opin Oncol,2002,14(2):171-179.
9Jiang S,Massarweh S,Osborne K,et al.Mechanisms of tamoxifen resistance:increased estrogen receptor-HER2/ neu cross-talk in ER/HER2-positive breast cancer[J]. National Cancer Institute,2004,96(2):926-935.
10Agrawal A,Gutteridge E,Gee J M W,et al.Overview of tyrosine kinase inhibitors in clinical breast cancer[J]. Endocrine Related Cancer,2005,12(3): 135-144.
